fashion -WSS

fashion

author：entertainment 2025-08-08 08:10:11 - browse：28

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： In Memoriam: Notable people who died in 2023

focus

explore

WSS

Walensky prepares to leave CDC — and Congress — behind

Malaria cases in Florida and Texas: Here’s what you need to know

Tori Bowie and the unacceptable rates of Black maternal death

Senate bill would ban some hospital facility fees

The struggle to figure out which patients 'deserve' Wegovy

Why the quest to eradicate polio has stumbled

leisure time

fashion

focus

How one medical school became remarkably diverse

Hollywood unions extend contract negotiations for actors

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What happened to the House vote on health price transparency?

Alkermes shareholders re

How one medical school became remarkably diverse

After affirmative action ruling, medical educators look to 'holistic review'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cancer drug shortages should be causing more outrage

PBMs drew scrutiny in House hearing — and so did pharma

leisure time

Why the drug industry's warnings on the IRA's impact fall short

23andMe had bad news about my health. I wish a person had delivered it

Tori Bowie and the unacceptable rates of Black maternal death

What happened to the House vote on health price transparency?

Medical records are filled with copy

State Dept. review finds Biden bears some blame for Afghanistan failures

explore

focus

explore

leisure time